News

Over 75 patients enrolled in BriaCell’s pivotal Phase 3 study of Bria-IMT ™ plus immune check point inhibitor in metastatic breast cancer (MBC) ...
The Trump administration's ban on transgender service members faces its next legal test Tuesday when a federal appeals court ...